Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1339-1346

  Ihnat, Michael A ^b   Lariviere, Jean P ^b   Warren, Amy J ^b   La Ronde, Nicole ^b   Blaxall, Johanna R N ^b   Pierre, Karana M ^b   Turpie, Bruce W ^b   Hamilton, Joshua W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 N [2 (4 NITROPHENYLDITHIO)ETHYL]MITOMYCIN C; CHROMIUM; CISPLATIN; DNA; DOXORUBICIN; GLYCOPROTEIN P; MITOMYCIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; DNA CROSS LINKING; GENE REPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CISPLATIN; COLONIC NEOPLASMS; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA, NEOPLASM; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; K562 CELLS; LIVER NEOPLASMS; MITOMYCIN; MITOMYCINS; NEUROBLASTOMA; P-GLYCOPROTEIN; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030806906     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dalton, W. S., and Sikic, B. I. Controversies in science: the multidrug resistance gene (MDR1) represents a potential target for reversing drug resistance in human malignancies. J. NIH Res., 6: 54-58, 1994.
2. Hayes, J. D., and Wolf, C. R. Molecular mechanisms of drug resistance. Biochem. J., 272: 281-295, 1990.
3. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
4. Fojo, A. T., Ueda, K., Slaman, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multi-resistance gene in human tumors and tissues. Proc. Natl, Acad. Sci. USA, 84: 265-269, 1987.
5. Roninson, I. B. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol., 43: 95-102, 1992.
6. Arceci, R. J. Clinical significance of p-glycoprotein in multidrug resistance malignancies. Blood, 81: 2215-2222, 1993.
7. Merkel, D. E., Fuqua, S. A., Tandon, A. K., Hill, S. M., Buzdar, A. U., and McGuire, W. L. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J. Clin. Oncol., 7: 1129-1136, 1989.
8. Biedler, J. L. Genetic aspects of multidrug resistance. Cancer (Phila.), 70: 1799-1809, 1992.
9. Sikic, B. I. Modulation of multidrug resistance: at the threshold. J. Clin. Oncol., 11: 1629-1635, 1993.
10. Hamilton, J. W., and Wetterhahn, K. E. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol. Carcinogen., 2: 274-286, 1989.
11. Hamilton, J. W., Louis, C. A., Doherty, K. A., Hunt, S. R., Reed, M. J., and Treadwell, M. D. Preferential alteration of inducible gene expression in vivo by carcinogens that induce bulky DNA lesions. Mol. Carcinogen., 8: 34-43, 1993.
12. Hamilton, J. W., McCaffrey, J., Caron, R. M., Louis, C. A., Treadwell, M. D., Hunt, S. R., Reed, M. J., and Doherty, K. A. Genotoxic chemical carcinogens target inducible genes in vivo. Ann. NY Acad. Sci., 726: 343-345, 1994.
13. Caron, R. M., and Hamilton, J. W. Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivo. Environ. Mol. Mutagen., 25: 4-11, 1995.
14. McCaffrey, J., Wolf, C. M., and Hamilton, J. W. Effects of the genotoxic carcinogen chromium(VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in vivo: correlation with glucocorticoid- and developmentally-regulated expression. Mol. Carcinogen., 10: 189-198, 1994.
15. McCaffrey, J., and Hamilton, J. W. Comparison of effects of direct-acting DNA methylating and ethylating agents on inducible gene expression in vivo. Environ. Mol. Mutagen., 23: 164-170, 1994.
16. Caron, R. M., Ihnat, M. A., and Hamilton, J. W. The promoter represents the critical target for the preferential effects of carcinogens on inducible gene expression, and chromatin structure is important for these effects. Proc. Am. Assoc. Cancer Res., 35: 142, 1994.
17. Caron, R. M., and Hamilton, J. W. Developmentally specific effects of mitomycin C on PEPCK gene expression and correlation with chromatin structure. Proc. Am. Assoc. Cancer Res., 36: 158, 1995.
18. Hamilton, J. W., Bement, W. J., Sinclair, P. R., Sinclair, J. F., and Wetterhahn, K. E. Expression of 5-aminolaevulinate synthase and cytochrome P-450 in chicken embryo hepatocytes in vivo and in cell culture: effect of porphyrinogenic drugs and haem. Biochem. J., 255: 267-275, 1988.
19. Hamilton, J. W., Bement, W. J., Sinclair, P. R., Sinclair, J. F., Alcedo, J. A, and Wetterhahn, K. E. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch. Biochem. Biophys., 289: 387-392, 1991.
20. Hamilton, J. W., Bement, W. J., Sinclair, P. R., Sinclair, J. F., Alcedo, J. A., and Wetterhahn, K. E. Inhibition of protein synthesis increases the transcription of the phenobarbital-inducible CYP2H1 and CYP2H2 genes in chick embryo hepatocytes. Arch. Biochem. Biophys., 298: 96-104, 1992.
21. McCaffrey, J., and Hamilton, J. W. Developmental regulation of basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in chick embryo liver in vivo. Arch. Biochem. Biophys., 309: 10-17, 1994.
22. Silverman, J. A., Raunio, H., Gant, T. W., and Thorgeirsson, S. S. Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene (Amst.), 106: 229-236, 1991.
23. Thorgeirsson, S. S., Silverman, J. A., Gant, T. W., and Marino, P. A. Multidrug resistance gene family and chemical carcinogens. Pharmacol. & Ther., 49: 283-292, 1991.
24. Miyazaki, M., Kohno, K., Uchiumi, T., Tanimura, H., Matsuo, K., Nasu, M., and Kuwano, M. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Commun., 187: 677-684, 1992.
25. Chieli, E., Santoni-Rugiu, E., Cervelli, F., Sabbatini, A., Petrini, M., Roiniti, N., Paolicchi, A., and Tongiani, R. Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholanthrene in rat hepatocyte primary cultures. Carcinogenesis (Lond.), 15: 335-341, 1994.
26. Caron, R. M., and Hamilton, J. W. The DNA crosslinking agent mitomycin C alters hormone-and drug-inducible gene expression in vivo. Proc. Am. Assoc. Cancer Res., 34: 5, 1993.
27. Tomasz, M., Lipman, R., Chowdary, D., Pawlak, J., Verdine, G. L., and Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Washington DC), 235: 1204-1208, 1987.
28. Borowy-Borowski, H., Lipman, R., and Tomasz, M. Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry, 29: 2999-3006, 1990.
29. Yajima, N., Hochi, S., Miyata, N., Kishi, T., and Kawanishi, G. DNA breaks and repair in the mouse leukemia L1210 cells exposed to three different types of interstrand DNA cross-linkers. Mutat. Res., 236: 43-50, 1990.
30. Garrison, J. C. Measurement of hormone-stimulated protein phosphorylation in intact cells. Methods Enzymol., 99: 20-36, 1983.
31. Gallagher, S. Immunoblotting and immunodetection. In: F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (eds.), Current Protocols in Molecular Biology, pp. 10.8.1-10.8.17. New York: John Wiley & Sons, Inc, 1995.
32. Gant, T. W., Silverman, J. A., Bisgaard, H. C. Burt, R. K., Marino, P. A., and Thorgeirsson, S. S. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinog., 4: 499-509, 1991.
33. Beale, E. G., Schaefer, I. M., and Li, Q. Culture at high density increases phosphoenolpyruvate carboxykinase messenger RNA in H4IIEC3 hepatoma cells. Mol. Endocrinol., 5: 661-669, 1991.
34. den Hartigh, J., McVie, J. G., van Ort, W. J., and Pinedo, H. M. Pharmacokinetics of mitomycin C in humans. Cancer Res., 43: 5017-5021, 1983.
35. Cohen, D., Yang, C-P. H., and Horwitz, S. B. The products of the mdr\a and mdrlb genes from multidrug resistant murine cells have similar degradation rates. Life Sci., 46: 489-495, 1990.
36. Graham, C. H., Kobayashi, H., Stankiewicz, K. S., Man, S., Kapitain, S. J., and Kerbel, R. S. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J. Natl. Cancer Inst., 86: 975-982, 1994.
37. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
38. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53: 1475-1479, 1993.
39. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
40. Anthony, S. P., Ihnat, M. A., Ernstoff, M. S., Kaufman, P. A., Lewis, L. D., Barth, R. J., Memoli, V. A., Dain, B. J., Arvizu, C. I., MacKay, K., Daly-Finn, L., and Hamilton, J. W. Suppression in expression of p-glycoprotein and other proteins associated with multidrug resistance (MDR) by mitomycin C in metastatic breast cancer patients: preliminary results from a pilot clinical trial. Proc. Am. Assoc. Clin. Oncol., 36: 374, 1996.